Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 11
Submit an article Journal homepage
307
Views
15
CrossRef citations to date
0
Altmetric
Letter to the Editor

Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials*

Laura GengenbachDepartment of Hematology, Oncology, Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany; View further author information
,
Heike ReinhardtDepartment of Hematology, Oncology, Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany; View further author information
,
Gabriele IhorstClinical Trials Unit, University Medical Center Freiburg, Freiburg, Germany; View further author information
,
Stefanie AjayiDepartment of Hematology, Oncology, Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany; ;Comprehensive Cancer Center Freiburg (CCCF), University Medical Center Freiburg, Freiburg, Germany; View further author information
,
Sandra Maria DoldDepartment of Hematology, Oncology, Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany; View further author information
,
Martin KöhlerDepartment of Hematology, Oncology, Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany; View further author information
,
Hermann EinseleMedizinische Klinik und Poliklinik II, Klinikum der Bayrischen Julius-Maximilians-Universität, Würzburg, GermanyView further author information
,
Justus DuysterDepartment of Hematology, Oncology, Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany; ;Comprehensive Cancer Center Freiburg (CCCF), University Medical Center Freiburg, Freiburg, Germany; View further author information
,
Ralph WäschDepartment of Hematology, Oncology, Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany; ;Comprehensive Cancer Center Freiburg (CCCF), University Medical Center Freiburg, Freiburg, Germany; View further author information
&
Monika EngelhardtDepartment of Hematology, Oncology, Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany; ;Comprehensive Cancer Center Freiburg (CCCF), University Medical Center Freiburg, Freiburg, Germany; Correspondence[email protected]
View further author information
 show all
Pages 2692-2699 | Received 30 Oct 2017, Accepted 21 Feb 2018, Published online: 23 Mar 2018

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Tilman Hans Steinmetz, Moushmi Singh, Andrea Lebioda, Leah Fink, Martina Schoehl, Achim Rieth, Sebastian Gonzalez-McQuire & Monika Engelhardt. (2021) Healthcare resource utilization and costs among patients with relapsed and/or refractory multiple myeloma treated with proteasome inhibitors in real-world clinical practice in Germany. Journal of Medical Economics 24:1, pages 114-122.
Read now
Giulia Graziani, Georg W. Herget, Gabriele Ihorst, Mara Zeissig, Aristeidis Chaidos, Holger W. Auner, Justus Duyster, Ralph Wäsch & Monika Engelhardt. (2020) Time from first symptom onset to the final diagnosis of multiple myeloma (MM) – possible risks and future solutions: retrospective and prospective ‘Deutsche Studiengruppe MM’ (DSMM) and ‘European Myeloma Network’ (EMN) analysis. Leukemia & Lymphoma 61:4, pages 875-886.
Read now

Articles from other publishers (13)

Amanda Ribbands, Natalie Boytsov, Abigail Bailey, Boris Gorsh, Emily Luke & Annabel Lambert. (2023) Drivers of physician decision-making and patient perspectives across lines of therapy in multiple myeloma in the USA. Future Oncology 19:22, pages 1549-1562.
Crossref
Benedikt Frank, Gabriele Ihorst, Georg Herget, Henning Schäfer, Jakob Neubauer, Marc-Antoine Calba, Daniel Textor, Mandy-Deborah Möller, Sina Wenger, Johannes Jung, Johannes Waldschmidt, Cornelius Miething, Michael Rassner, Christine Greil, Ralph Wäsch & Monika Engelhardt. (2022) Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers. Annals of Hematology 102:3, pages 603-611.
Crossref
Monika Engelhardt, Gabriele Ihorst, Martin Schumacher, Michael Rassner, Laura Gengenbach, Mandy Möller, Khalid Shoumariyeh, Jakob Neubauer, Juliane Farthmann, Georg Herget & Ralph Wäsch. (2021) Multidisciplinary tumor boards and their analyses: the yin and yang of outcome measures. BMC Cancer 21:1.
Crossref
Laura Gengenbach, Giulia Graziani, Heike Reinhardt, Amelie Rösner, Magdalena Braun, Mandy-Deborah Möller, Christine Greil, Ralph Wäsch & Monika Engelhardt. (2021) Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors. Cancers 13:17, pages 4320.
Crossref
Cyrille Touzeau, Nadia Quignot, Jie Meng, Heng Jiang, Artak Khachatryan, Moushmi Singh, Vanessa Taieb, Jean-Vannak Chauny & Gaëlle Désaméricq. (2021) Survival and treatment patterns of patients with relapsed or refractory multiple myeloma in France — a cohort study using the French National Healthcare database (SNDS). Annals of Hematology 100:7, pages 1825-1836.
Crossref
Shinsuke Iida, Kazutaka Sunami, Hironobu Minami, Kiyohiko Hatake, Risa Sekiguchi, Kazuto Natsume, Norifumi Ishikawa, Mikael Rinne & Masafumi Taniwaki. (2021) A phase I, dose-escalation study of oral PIM447 in Japanese patients with relapsed and/or refractory multiple myeloma. International Journal of Hematology 113:6, pages 797-806.
Crossref
Mandy-Deborah Möller, Gabriele Ihorst, Antonia Pahl, Sophia Scheubeck, Friedrich Barsch, Sandra Maria Dold, Hartmut Bertz, Jann Arends, Ralph Wäsch & Monika Engelhardt. (2021) Physical activity is associated with less comorbidity, better treatment tolerance and improved response in patients with multiple myeloma undergoing stem cell transplantation. Journal of Geriatric Oncology 12:4, pages 521-530.
Crossref
Monika Engelhardt, Gabriele Ihorst, Moushmi Singh, Achim Rieth, Grèce Saba, Marine Pellan & Andrea Lebioda. (2021) Real-World Evaluation of Health-Related Quality of Life in Patients With Multiple Myeloma From Germany. Clinical Lymphoma Myeloma and Leukemia 21:2, pages e160-e175.
Crossref
Yanfang Liu, Chao-Hsiun Tang, Hong Qiu, Sarah Siggins & Hsin-An Hou. (2021) Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwan. Scientific Reports 11:1.
Crossref
Maximilian Schinke, Gabriele Ihorst, Justus Duyster, Ralph Wäsch, Martin Schumacher & Monika Engelhardt. (2020) Risk of disease recurrence and survival in patients with multiple myeloma: A German Study Group analysis using a conditional survival approach with long‐term follow‐up of 815 patients. Cancer 126:15, pages 3504-3515.
Crossref
Monika Engelhardt, Khalid Shoumariyeh, Amelie Rösner, Gabriele Ihorst, Francesca Biavasco, Katharina Meckel, Ivana von Metzler, Sebastian Treurich, Holger Hebart, Matthias Grube, Miriam Kull, Florian Bassermann, Kerstin Schäfer-Eckart, Anette Hoferer, Hermann Einsele, Leo Rasche & Ralph Wäsch. (2020) Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany. Haematologica 105:12, pages 2872-2878.
Crossref
Sebastian Küchlin, Johannes Duffner, Sophia Scheubeck, Katja Schoeller, Lars Maruschke, Maximilian Seidl, Monika Engelhardt, Gerd Walz, Eric Peter Prager & Johannes Moritz Waldschmidt. (2018) Kidney embolization induces prompt organ response in a 86‐year‐old patient with MGRS‐related AL‐amyloidosis. Hemodialysis International 23:2, pages E59-E64.
Crossref
Mingyang Deng, Huan Yuan, Sufang Liu, Zhiping Hu & Han Xiao. (2019) Exosome-transmitted LINC00461 promotes multiple myeloma cell proliferation and suppresses apoptosis by modulating microRNA/BCL-2 expression. Cytotherapy 21:1, pages 96-106.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.